Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

John Martin

OTHER INVESTOR TYPE
3 INVESTMENTS
1 PORTFOLIO
1 EXITS
Description

Dr. John Martin serves as the Chairman at Arresto BioSciences. He served as the Chairman and Executive Chairman and Director at Gilead Sciences. He served as President and Chief Executive Officer from 1996 through May 2008. Prior to joining Gilead, Dr. Martin held several leadership positions at Bristol-Myers Squibb and Syntex Corporation. Dr. Martin is a member of the Board of Directors of the California Healthcare Institute. He also serves on the University of Southern California Board of Trustees. Dr. Martin previously served as President of the International Society for Antiviral Research, Chairman of the Board of Directors of BayBio and Chairman of the Board of Directors of the California Healthcare Institute. He served on the National Institute of Allergy & Infectious Diseases Council, the Board of Directors of the Biotechnology Industry Organization, the Board of Trustees of the University of Chicago, the Board of Trustees of Golden Gate University and the External Scientific Advisory Board of the University of California School of Global Health. Additionally, Dr. Martin served on the Centers for Disease Control/Health Resources and Services Administration's Advisory Committee on HIV and STD Prevention and Treatment and was a member of the Presidential Advisory Council on HIV/AIDS. Dr. Martin holds a PhD in organic chemistry from the University of Chicago and an MBA in marketing from Golden Gate University. He has received the Isbell Award from the American Chemical Society and the Gertrude B. Elion Award for Scientific Excellence from the International Society for Antiviral Research. In 2008, Dr. Martin was inducted into the National Academy of Engineering of the National Academies. He serves as a Board Member at Kronos Bio.

Primary Investor Type
Angel (individual)
Primary Office
  • 3183 Porter Drive
  • Palo Alto, CA 94304
  • United States

+1 (650) 000-0000

John Martin Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Kronos Bio 13-Jul-2019 Early Stage VC 00000 Biotechnology Startup 0000 000000 00.0
000000 000 23-May-2018 0000 00000 0000 Biotechnology Startup 0000 000000 00.0
000000000 01-Sep-2014 0000 00000 00000 Electronics (B2C) Profitable
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore John Martin’s full profile, request a free trial.

John Martin Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 01-May-2018 0000000000 Completed
  • 4 buyers
To view this investor’s complete exits history, request access »

John Martin Team (1)

Name Title Deals Funds Boards Office Contact
Info
John Martin Ph.D Angel Investor 0 0 Palo Alto, CA